Arab Israeli Conflict
Hi Tech News
Mylan rejected Teva's $41 billion bid earlier this week.
Teva developing more than 70 innovative drugs
For a long time, market rumors have persisted that Yanai was on his way out.
The company confirmed the new layoffs on Thursday afternoon, after releasing a disappointing second quarter earnings report earlier in the day.
By SHARON UDASIN
The approval makes Israel one of the first countries to implement it.
By JUDY SIEGEL-ITZKOVICH
Teva CEO says acquisition delivers on strategy of increasing presence in key emerging markets.
Sami Miaari says that “the big drug pharmaceutical companies are not hiring Arabs.”
By ARIEL BEN SOLOMON
Constable David Hopkinson said the deaths are ''suspicious'' and being treated as such.
Israel could be in prime position to take advantage of the lucrative opportunity provided by the personalized medicine era.
By EYTAN HALON
“The move will prevent suffering from those who are required to use this medically [and] deal with the unnecessary bureaucracy that exists in the field,” Litzman said.
Approximately 20 percent to 25 percent of patients with hereditary breast cancers and up to 10 percent of patients with any type of breast cancer have a BRCA mutation.
Channel 10 probe on ‘pay for play’ shakes health system.
Please insert a valid email address